Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CE-mark for rapid heartbeat ablation catheter:

This article was originally published in Clinica

Executive Summary

Cardima has CE-marked its second microcatheter for treating atrial fibrillation. Like the company's Revelation microcatheter, which was cleared for treating the condition in August 1998, the Revelation TX device ablates heart tissue laterally rather than at the tip. The new microcatheter can also determine atrial tissue temperature during an ablation procedure, which could help doctors reduce the chances of blood clot formation, said the Fremont, California-based company.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT082753

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel